Jul 3 |
Korro Bio: Interesting RNA Biotech With 2nd Half 2025 Interim Data
|
Jul 1 |
Korro Bio joins Russell 2000, Russell 3000, Russell Microcap indexes
|
Jul 1 |
Korro Joins the Russell 2000®, Russell 3000®, and Russell Microcap® Indexes
|
May 30 |
Korro to Participate in Upcoming June Investor and Scientific Conferences
|
May 20 |
Korro Presents Additional Preclinical Data for KRRO-110 at the American Thoracic Society 2024 International Conference
|
May 15 |
Korro Bio reports Q1 GAAP EPS of -$2.44
|
May 14 |
Korro Reports First Quarter 2024 Financial Results and Appointment of Kemi Olugemo, M.D. as Chief Medical Officer
|
Apr 18 |
Korro secures $70M financing via private placement
|
Apr 18 |
Korro Bio launches $70M PIPE offering
|
Apr 18 |
Korro Announces $70 Million Private Placement
|